Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Intellia Therapeutics, Inc. (NTLA) had Return on Tangible Equity of -13.54% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$13.78M |
|
$-101.32M |
|
-- |
|
$13.78M |
|
$125.26M |
|
$-111.48M |
|
$10.15M |
|
$-101.32M |
|
$-101.32M |
|
$-101.32M |
|
$-101.32M |
|
$-101.32M |
|
$-101.32M |
|
$-111.48M |
|
$-106.54M |
|
110.19M |
|
110.19M |
|
$-0.92 |
|
$-0.92 |
|
| Balance Sheet Financials | |
$581.94M |
|
$20.42M |
|
$343.33M |
|
$925.27M |
|
$93.73M |
|
-- |
|
$83.13M |
|
$176.85M |
|
$748.42M |
|
$748.42M |
|
$748.42M |
|
115.79M |
|
| Cash Flow Statement Financials | |
$-325.45M |
|
$200.50M |
|
$129.51M |
|
$202.79M |
|
$207.34M |
|
$4.55M |
|
$63.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-808.86% |
|
-808.86% |
|
-- |
|
-735.19% |
|
-735.19% |
|
$-326.45M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.25 |
|
72.16 |
|
-13.54% |
|
|
Return on Tangible Equity |
-13.54% |
-10.95% |
|
-13.54% |
|
$6.46 |
|
$-2.96 |
|
$-2.95 |
|